Predictive value of pre-therapy (18)F-FDG PET/CT for the outcome of (18)F-FDG PET-guided radiotherapy in patients with head and neck cancer.
about
PET/CT with (11)C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data.Metabolic tumour volume as a prognostic factor for oral cavity squamous cell carcinoma treated with primary surgeryCombined PET/CT-perfusion in patients with head and neck cancers might predict failure after radio-chemotherapy: a proof of concept studyThe relative prognostic utility of standardized uptake value, gross tumor volume, and metabolic tumor volume in oropharyngeal cancer patients treated with platinum based concurrent chemoradiation with a pre-treatment [(18)F] fluorodeoxyglucose positImaging biomarkers in prostate cancer: role of PET/CT and MRI.The role of PET/CT in the management of patients affected by head and neck tumors: a review of the literature.Impact of partial-volume correction in oncological PET studies: a systematic review and meta-analysis.Impact of 68Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy.A review of the predictive role of functional imaging in patients with mucosal primary head and neck cancer treated with radiation therapy.Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist.18F-FDG PET-CT performed before and during radiation therapy of head and neck squamous cell carcinoma: Are they independent or complementary to each other?PET Radiomics in NSCLC: state of the art and a proposal for harmonization of methodology.PET and PET/CT with radiolabeled choline in prostate cancer: a critical reappraisal of 20 years of clinical studies.Early volume variation of positive lymph nodes assessed by in-room mega voltage CT images predicts risk of loco-regional relapses in head and neck cancer patients treated with intensity-modulated radiotherapy.Biomarkers from in vivo molecular imaging of breast cancer: pretreatment 18F-FDG PET predicts patient prognosis, and pretreatment DWI-MR predicts response to neoadjuvant chemotherapy.Whole Body Metabolic Tumor Volume and Total Lesion Glycolysis Predict Survival in Patients with Adrenocortical Carcinoma.Impact of total lesion glycolysis measured by (18)F-FDG-PET/CT on overall survival and distant metastasis in hypopharyngeal cancer.Functional imaging to predict treatment response after (chemo) radiotherapy of head and neck squamous cell carcinoma.Hypoxic glucose metabolism in glioblastoma as a potential prognostic factor.The use of PET/CT in prostate cancer.Predictive markers, including total lesion glycolysis, for the response of lymph node(s) metastasis from head and neck squamous cell carcinoma treated by chemoradiotherapy.Clinical impact of 18 F-FDG positron emission tomography/CT on adenoid cystic carcinoma of the head and neck.Radiomic Profiling of Head and Neck Cancer: F-FDG PET Texture Analysis as Predictor of Patient Survival
P2860
Q31003607-9088E72D-FB08-4D4F-9CDC-B7728B149EADQ34346395-E5D18BFC-7161-4243-9322-4B327074DA34Q36416979-79D4E8A7-E97C-4C35-87D8-B78A198A560FQ37192658-7F6F07CE-9404-459C-BFDD-296E22B1F419Q38321182-CD6A7057-E47D-49D1-8D53-9FC0AAC81CDCQ38478344-9F2F43CB-B3D7-49F5-A170-82C18F54803EQ38641832-A8E16AF5-0B2B-4C0D-BEA7-65D654810BBFQ38804450-45CA8B78-79C0-4A1E-AEA2-9E0127DD451FQ38836743-6C8312F9-6AC7-4E12-9D5E-53518320DE09Q38896865-376ADD56-5CF3-49B5-8506-BD9CE65F5757Q38909224-E957C4EB-E0B0-4936-88D3-DF5459F4E172Q39197536-B96316B0-8C0D-4476-8793-8B696E16DF99Q39242140-D910DE60-395B-49B1-B653-CCD01D619EBDQ40704410-C83216DB-913F-444E-AC80-F2F8AD0A5828Q41109140-5866C5F8-A0F1-4645-BB0A-40E2D6173DCEQ41474991-51F99DA0-9530-4F4C-9673-A743333887FFQ41777552-2D862AD8-EE3E-4CD9-BA92-618846664AD3Q42737820-A0674D3A-D301-4332-B75F-0468064D2235Q48474503-12DF1C18-7CEE-4A27-8FDB-C4DB0A293EF1Q49919217-02A70094-8E65-4D0E-821A-DDF3C52DF4FFQ52924821-18F9D7EF-1F8F-4A33-B3E0-D0E58D6FD3F3Q52969080-1E49E0AA-D57D-43AF-B95A-7A11CF86AE4AQ58549064-E1AD83C1-4B53-4667-83B4-93D34D626365
P2860
Predictive value of pre-therapy (18)F-FDG PET/CT for the outcome of (18)F-FDG PET-guided radiotherapy in patients with head and neck cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Predictive value of pre-therap ...... nts with head and neck cancer.
@en
Predictive value of pre-therapy
@nl
type
label
Predictive value of pre-therap ...... nts with head and neck cancer.
@en
Predictive value of pre-therapy
@nl
prefLabel
Predictive value of pre-therap ...... nts with head and neck cancer.
@en
Predictive value of pre-therapy
@nl
P2093
P2860
P50
P1476
Predictive value of pre-therap ...... nts with head and neck cancer.
@en
P2093
P2860
P2888
P356
10.1007/S00259-013-2528-2
P577
2013-08-29T00:00:00Z